• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 7 of 100
An older man wearing a business suit holds a pill in one hand and a glass of water in the other.
HealthThe aspirin mistake: 29 million take it daily, not realizing costs outweigh benefits
By Lindsey LeakeFebruary 3, 2025
A person stands on a scale.
HealthHims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By Lindsey LeakeFebruary 3, 2025
Ozempic and Wegovy medications side by side
HealthOzempic and Wegovy surge to national approval with most U.S. adults considering it ‘a good thing’ to treat obesity
By The Associated Press, Kenya Hunter and Linley SandersJanuary 31, 2025
Close-up view of man in blue button-down shirt placing pills in his hand.
HealthNew pain drug, Vertex’s Journavx, gets FDA approval as safer alternative to addictive opioids
By Bloomberg and Gerry SmithJanuary 31, 2025
Pattern of colorful pills and capsules on beige background.
HealthCigna plans to limit out-of-pocket drug costs for U.S. patients
By Bloomberg and John TozziJanuary 30, 2025
The increase in online searches for obesity management drugs in recent years correlated to a surge in dispensed prescriptions, according to a new study from the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease.
HealthOnline searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By Lindsey LeakeJanuary 29, 2025
A person, with only the midsection visible, injects Wegovy under the skin of their stomach.
FinanceNovo Nordisk stock surges 7% after Ozempic maker’s latest weight-loss drug shows promise
By Greg McKennaJanuary 24, 2025
Man, seen from the back, sitting on unmade bed and looking out a window.
MindFDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
By Beth GreenfieldJanuary 22, 2025
Days before President Donald Trump took office a second time, the Department of Health and Human Services granted Moderna $590 million for the development of mRNA vaccines for bird flu and other influenza viruses.
HealthAs bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
By Lindsey LeakeJanuary 22, 2025
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication in the works that could be approved by the FDA as early as 2026, CEO Dave Ricks told Bloomberg TV on Jan. 13, 2025.
HealthHate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
By Lindsey LeakeJanuary 21, 2025
Chairman & Chief Executive Officer of LVMH, Bernard Arnault attends the Viva Technology show at Parc des Expositions Porte de Versailles on May 23, 2024 in Paris, France.
SuccessLVMH dethrones Novo Nordisk as Europe’s most valuable company as Bernard Arnault adds $12 billion to net worth in 2025
By Ryan HoggJanuary 20, 2025
Walgreens accused of filling millions of illegitimate prescriptions, including for opioids
RetailWalgreens accused of filling millions of illegitimate prescriptions, including for opioids
By The Associated PressJanuary 18, 2025
Danish Prime Minister Mette Frederiksen (R) and Greenlandic Prime Minister Mute Bourup Egede address a press conference in the Mirror Hall at the Prime Minister's Office, at Christiansborg in Copenhagen, on January 10, 2025.
LeadershipNovo Nordisk CEO attends crisis talks with Danish PM amid Donald Trump Greenland threats
By Ryan HoggJanuary 17, 2025
Woman waiting in line at Walgreens near refrigerators
RetailWalgreens replaced its refrigerator doors with digitized ad-laden glass. It might become a $200 million debacle
By Sydney LakeJanuary 17, 2025
CEO of UnitedHealth Group sits in a blue suit testifying before Congress
FinanceUnitedHealth CEO calls out pharmaceutical companies for inflating prices in first earnings call since executive was murdered
By Hallie SteinerJanuary 16, 2025
1...
  • 5
  • 6
  • 7
  • 8
  • 9
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Politics
You're probably safe from the Hantavirus outbreak, but here's what you absolutely must not do, experts sayplaceholder alt text
By Catherina GioinoMay 8, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.